Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy

Journal of Clinical Oncology

Volumn 22, Issue 20, 2004, Pages 4067-4074

  Low, Jennifer A ^a   Berman, Arlene W ^a   Steinberg, Seth M ^a   Danforth, David N ^a   Lippman, Marc E ^a   Swain, Sandra M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; TAMOXIFEN; ALKYLATING AGENT; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; AXILLA; BREAST; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; LONG TERM CARE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; ADJUVANT THERAPY; ADULT; AGED; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; INFLAMMATION; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; SURVIVAL RATE;

EID: 7044272570     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.04.068     Document Type: Article

References (30)

1. Haagensen CD, Stout AP: Carcinoma of the breast: II. Criteria of operability (continued). Ann Surg 118:1032-1051, 1943
2. Haagensen CD: Inflammatory Carcinoma, Disease of the Breast. Philadelphia, PA, W.B. Saunders, 1971, pp 576-584
3. Hortobagyi GN, Buzdar AU, Strom EA, et al: Primary chemotherapy for early and advanced breast cancer. Cancer Lett 90:103-109, 1995
4. Brito RA, Valero V, Buzdar AU, et al: Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 19:628-633, 2001
5. Baillet F, Rozec C, Ucla L, et al: Treatment of locally advanced breast cancer without mastectomy: 5- and 10-year results of 135 tumors larger than 5 centimeters treated by external beam therapy, brachytherapy, and neoadjuvant chemotherapy. Ann N Y Acad Sci 698:264-270, 1993
6. Perez CA, Fields JN, Fracasso PM, et al: Management of locally advanced carcinoma of the breast: II. Inflammatory carcinoma. Cancer 74:466-476, 1994
7. Sheldon T, Hayes DF, Cady B, et al: Primary radiation therapy for locally advanced breast cancer. Cancer 60:1219-1225, 1987
8. Chang S, Parker SL, Pham T, et al: Inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992. Cancer 82:2366-2372, 1998
9. Attia-Sobol J, Ferriere JP, Cure H, et al: Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysis. Eur J Cancer 29A:1081-1088, 1993
10. Rouesse J, Friedman S, Sarrazin D, et al: Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol 4:1765-1771, 1986
11. Pawlicki M, Skolyszewski J, Brandys A: Results of combined treatment of patients with locally advanced breast cancer. Tumori 69:249-253, 1983
12. Fields JN, Perez CA, Kuske RR, et al: Inflammatory carcinoma of the breast: Treatment results on 107 patients. Int J Radiat Oncol Biol Phys 17:249-255, 1989
13. Brun B, Otmezguine Y, Feuilhade F, et al: Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer 61:1096-1103, 1988
14. Ueno NT, Buzdar AU, Singletary SE, et al: Combined-modality treatment of inflammatory breast carcinoma: Twenty years of experience at M. D. Anderson Cancer Center. Cancer Chemother Pharmacol 40:321-329, 1997
15. Harris EE, Schultz D, Bertsch H, et al: Ten-year outcome after combined modality therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys 55:1200-1208, 2003
16. Palangie T, Mosseri V, Mihura J, et al: Prognostic factors in inflammatory breast cancer and therapeutic implications. Eur J Cancer 30A:921-927, 1994
17. Mourali N, Tabbane F, Muenz LR, et al: Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic, rapidly progressing breast cancer. Cancer Invest 11:363-370, 1993
18. Noguchi S, Miyauchi K, Nishizawa Y, et al: Management of inflammatory carcinoma of the breast with combined modality therapy including intraarterial infusion chemotherapy as an induction therapy: Long-term follow-up results of 28 patients. Cancer 61:1483-1491, 1988
19. Wiseman CL: Inflammatory breast cancer: 10-year follow-up of a trial of surgery, chemotherapy, and allogeneic tumor cell/BCG immunotherapy. Cancer Invest 13:267-271, 1995
20. Liauw SL, Benda RK, Morris CG, et al: Inflammatory breast carcinoma: Outcomes with trimodality therapy for nonmetastatic disease. Cancer 100:920-928, 2004
21. Swain SM, Sorace RA, Bagley CS, et al: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 47:3889-3894, 1987
22. Pierce LJ, Lippman M, Ben-Baruch IM, et al: The effect of systemic therapy on local-regional control in locally advanced breast cancer. Int J Radiat Oncol Biol Phys 23:949-960, 1992
23. Danforth DN Jr, Zujewski J, O'Shaughnessy J, et al: Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer. Ann Surg Oncol 5:150-158, 1998
24. Lippman ME, Cassidy J, Wesley M, et al: A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization. J Clin Oncol 2:28-36, 1984
25. Mehta CR, Patel NR: A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 78:427-434, 1983
26. Joensuu H, Toikkanen S: Cured of breast cancer? J Clin Oncol 13:62-69, 1995
27. Weiss RB, Woolf SH, Demakos E, et al: Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: A study by the Cancer and Leukemia Group B. J Clin Oncol 21:1825-1835, 2003
28. Fisher B, Bryant J, Wolmark N, et al: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685, 1998
29. De Boer RH, Allum WH, Ebbs SR, et al: Multimodality therapy in inflammatory breast cancer: Is there a place for surgery? Ann Oncol 11:1147-1153, 2000
30. Fleming RY, Asmar L, Buzdar AU, et al: Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Ann Surg Oncol 4:452-461, 1997